Article
Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma.
Nature communications - 12 Jan 2022
Schick Markus, Zhang Le, Maurer Sabine, Maurer Hans Carlo, Isaakaidis Konstandina, Schneider Lara, Patra Upayan, Schunck Kathrin, Rohleder Elena, Hofstetter Julia, Baluapuri Apoorva, Scherger Anna Katharina, Slotta-Huspenina Julia, Hettler Franziska, Weber Julia, Engleitner Thomas, Maresch Roman, Slawska Jolanta, Lewis Richard, Istvanffy Rouzanna, Habringer Stefan, Steiger Katja, Baiker Armin, Oostendorp Robert A J, Miething Cornelius, Lenhof Hans-Peter, Bassermann Florian, Chapuy Björn, Wirth Matthias, Wolf Elmar, Rad Roland, Müller Stefan, Keller Ulrich
Abstract excerpt
SUMOylation is a post-translational modification of proteins that regulates these proteins' localization, turnover or function. Aberrant SUMOylation is frequently found in cancers but its origin remains elusive. Using a genome-wide transposon mutagenesis screen in a MYC-driven B-cell lymphoma model, we here identify the SUMO isopeptidase (or deconjugase) SENP6 as a tumor suppressor that links unrestricted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
